GreenLight Biosciences (GRNA) confirmed that it has received a non-binding indication of interest from Fall Line Endurance Fund, L.P. to acquire all of the outstanding

According to Bloomberg, BridgeBio Pharma (BBIO) which develops treatments for genetic diseases, is attracting takeover interest from bigger drug companies, according to people familiar with

Echo Lake Capital offers to acquire Quince Therapeutics (QNCX) for $1.60 per share in cash.

According to Financial Times, Richard Branson’s Virgin Orbit (VORB) is in discussions with two financial investors about a potential buyout or fundraising.

According to Bloomberg, First Republic Bank (FRC) the San Francisco-based lender is exploring strategic options including a sale. Update(s): March 16, 2023: According to WSJ,

According to Reuters, Infinera Corp (INFN), a U.S. manufacturer of semiconductors for the telecommunications industry that competes with China’s Huawei, is exploring options that include

The Board of Directors of Jounce Therapeutics (JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, confirmed

Synchronoss Technologies (SNCR),  confirmed that on March 10, 2023, it received a non-binding proposal from B. Riley Financial to acquire all outstanding shares of the

Nano Dimension (NNDM), a leading supplier of Additively Manufactured Electronics and multi-dimensional polymer, metal & ceramic Additive Manufacturing 3D printers, announced that it has made

Neoleukin Therapeutics (NLTX), announced that it has engaged SVB Securities to assist in reviewing strategic alternatives for the company with the goal of maximizing shareholder